...
首页> 外文期刊>Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer >Management of bone health in postmenopausal women on aromatase inhibitors (AIs): a single health care system experience
【24h】

Management of bone health in postmenopausal women on aromatase inhibitors (AIs): a single health care system experience

机译:芳香酶抑制剂(AIS)骨髓女性骨骼健康管理:单一医疗保健系统经验

获取原文
获取原文并翻译 | 示例
           

摘要

Aromatase inhibitors (AIs) are the preferred therapy for postmenopausal women with early-stage estrogen receptor-positive breast cancers. However, their use causes bone loss and increased risks of osteoporosis and fractures.
机译:芳族酶抑制剂(AIS)是患有早期雌激素受体阳性乳腺癌的绝经后妇女的优选疗法。 然而,它们的使用会导致骨丢失和骨质疏松症和骨折的风险增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号